Series B funding round for Immunitas Therapeutics raising $58M in August 2021
Series B funding round for Immunitas Therapeutics raising $58M in August 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Netalie Nadivi |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$97M
Top Valuation
-
Immunitas Therapeutics raised $58M in a Series B round.
The round was announced on 08/01/21.